Fuller & Thaler Asset Management, Inc. Pacific Biosciences Of California, Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $1.08 Million - $2.12 Million	-271,384 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$2.05 - $3.23 $41,615 - $65,569	-20,300 Reduced 6.96%	271,384 $556,000
Q4 2017 Feb 12, 2018	SELL	$2.59 - $5.44 $242,566 - $509,483	-93,655 Reduced 24.3%	291,684 $770,000
Q3 2017 Nov 08, 2017	SELL	$3.2 - $5.57 $6,080 - $10,583	-1,900 Reduced 0.49%	385,339 $2.02 Million
Q2 2017 Aug 14, 2017	BUY	N/A	387,239	387,239 $1.38 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.